The WHI, twenty years later: what the study really showed.
One press conference in 2002 halved hormone therapy use within six months. The data that followed tells a different, more useful story — if you read past the headline.
In July 2002, the Women's Health Initiative announced that combined estrogen–progestin therapy increased the risk of breast cancer, heart disease, and stroke. Hormone therapy use fell by roughly half within six months. An entire generation of women — and their physicians — turned away from it. What happened to the science afterward received a fraction of the coverage.
What the trial actually studied
The average WHI participant was 63 years old — a full decade past menopause — and already carried meaningful baseline cardiovascular risk. The trial tested one regimen: daily oral conjugated equine estrogens with medroxyprogesterone acetate, a combination largely replaced in modern practice by transdermal estradiol and micronized progesterone. The results were real; the generalization of them to a 51-year-old with hot flashes was not.
What the re-analyses showed
When the data were re-examined by age, women who started hormone therapy within ten years of menopause did not show increased coronary risk — and showed a reduction in all-cause mortality. The estrogen-alone arm showed a non-significant reduction in breast cancer over seven-plus years. The combined-therapy breast cancer signal was real but small in absolute terms: roughly 9 additional cases per 10,000 women per year — comparable to risk factors like obesity, alcohol, or low physical activity.
Where the evidence has settled
Hormone therapy is the most effective treatment for vasomotor symptoms, prevents bone loss (hip fractures fell by about a third in the WHI itself), treats genitourinary symptoms — and, started in the right window in the right patient, is safe. It is not an anti-aging cure, and it is not used to prevent heart disease or dementia. Both the 2002 panic and today's "no risks, everyone should be on it" social media wave get the same treatment here: an honest reading of the data.
The cost of the headline
The deepest damage of 2002 was a generation of undertreated women and undertrained clinicians. If you were told years ago that you "can't" take hormones and have never had a detailed conversation about why — that conversation is overdue, and we would welcome having it with you.